Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.2.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.16 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.46.1 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.37 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.336SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.317SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.397SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.621.1 (Mu)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.7.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.32SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CK.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.16.1 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.9.7SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.72SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.7SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.20SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.73SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XDZSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XEBSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.263SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.180SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.464SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.234SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.231SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.243SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.517SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.291SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.258SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.349SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.314SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.132SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.38SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.42SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DL.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.15SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.529 (Omicron)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.41.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.39SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.20SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.33 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.10SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.15SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.14.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.14.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1 (Omicron)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.17.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.99.2 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JN.1.52SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used